Sign in
Explore the registryTrack Risvutatug rezetecan's trials

A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)

Risvutatug rezetecanOngoingNot yet recruitingPhase 1Open NCT07602855 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…